XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jul. 31, 2024
Jan. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,539,457 $ 1,558,252
Marketable securities 5,980,575 5,404,233
Accounts receivable, net of allowances of $22,799 and $32,371 as of July 31, 2024 and January 31, 2024, respectively 528,237 536,078
Deferred contract acquisition costs, current 197,502 208,474
Prepaid expenses and other current assets 149,374 219,182
Total current assets 8,395,145 7,926,219
Deferred contract acquisition costs, noncurrent 120,603 138,724
Property and equipment, net 347,714 293,704
Operating lease right-of-use assets 53,045 58,975
Strategic investments 438,529 409,222
Goodwill 307,295 307,295
Deferred tax assets 718,066 662,177
Other assets, noncurrent 126,795 133,477
Total assets 10,507,192 9,929,793
Current liabilities:    
Accounts payable 10,611 10,175
Accrued expenses and other current liabilities 439,459 500,164
Deferred revenue, current 1,391,278 1,251,848
Total current liabilities 1,841,348 1,762,187
Deferred revenue, noncurrent 15,416 18,514
Operating lease liabilities, noncurrent 36,052 48,308
Other liabilities, noncurrent 89,129 81,378
Total liabilities 1,981,945 1,910,387
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock, $0.001 par value per share, 2,000,000,000 Class A shares authorized as of July 31, 2024 and January 31, 2024; 262,335,183 and 260,896,822 shares issued and outstanding as of July 31, 2024 and January 31, 2024, respectively; 300,000,000 Class B shares authorized as of July 31, 2024 and January 31, 2024; 45,660,441 and 46,661,531 shares issued and outstanding as of July 31, 2024 and January 31, 2024, respectively 308 307
Additional paid-in capital 5,298,145 5,228,756
Accumulated other comprehensive income 2,191 1,063
Retained earnings 3,224,603 2,789,280
Total stockholders’ equity 8,525,247 8,019,406
Total liabilities and stockholders’ equity $ 10,507,192 $ 9,929,793